Powered by

Array BioPharma Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2018

Aug 14, 2018 - PR Newswire

 Array BioPharma Inc. (Nasdaq: ARRY) today reported results for its fourth quarter and full year of fiscal 2018 and provided an update on the progress of its key commercial products and clinical development programs.

"We were thrilled to launch BRAFTOVI(TM) + MEKTOVI® for patients withBRAF-mutant melanoma in the U.S. after receiving FDA approval for the combination in June. Since then, we have seen a very positive reception from melanoma healthcare providers. With the announcement of a m...